Trend of clinical trials of new drugs for rare diseases in China in recent 10 years
Abstract Background Rare disease is a general term for a disease that affects a small number of people but recognized as a global public health priority. Governments worldwide are paying more and more attention to the academical research and drug investment of rare diseases. The conduct of rare dise...
Main Authors: | Ai Peng, Xue Fan, Linling Zou, Huan Chen, Jin Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-023-02713-6 |
Similar Items
-
Current status and trend of clinical development of orphan drugs in China
by: Ziling Xiang, et al.
Published: (2022-07-01) -
A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial
by: Rebecca A. Crow, et al.
Published: (2018-05-01) -
Recent landscape and trends for industry‐sponsored pediatric clinical trials in China from 2013 to 2022
by: Chang Liu, et al.
Published: (2024-03-01) -
What role can decentralized trial designs play to improve rare disease studies?
by: J. Moore, et al.
Published: (2022-06-01) -
Clinical Trials of Rare Diseases in China over One Decade: Based on the Chinese First List of Rare Diseases
by: CHEN Chen, et al.
Published: (2022-11-01)